Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 32Gastrointestinal 16Head & Neck 11Sarcoma 4Lymphoid 3Dermatologic 3Breast 3Gynecologic 2CNS 2

Conditions

Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × endostar protein × Lymphoid × Clear all
NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, T-Cell

NCT02520219 2015-08-11

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 2 Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00974324 2010-09-15

PTCL

Fudan University

Phase 2 Unknown
15 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡